טוען...
Economic evaluation of first-line and maintenance treatments for advanced non-small cell lung cancer: a systematic review
During these last years, there have been an increased number of new drugs for non-small cell lung cancer (NSCLC), with a growing financial effect on patients and society. The purpose of this article was to review the economics of first-line and maintenance NSCLC treatments. We reviewed economic anal...
שמור ב:
| הוצא לאור ב: | Clinicoecon Outcomes Res |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Dove Medical Press
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4271788/ https://ncbi.nlm.nih.gov/pubmed/25548525 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S43328 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|